vs
Side-by-side financial comparison of MicroAlgo Inc. (MLGO) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.
Quipt Home Medical Corp. is the larger business by last-quarter revenue ($49.0M vs $26.3M, roughly 1.9× MicroAlgo Inc.). On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs -35.5%).
MicroAlgo Inc. is a technology enterprise specializing in custom algorithm optimization solutions. It mainly serves clients across smart city management, industrial internet, and e-commerce sectors, helping enterprises improve operational efficiency, reduce operating costs, and optimize data processing performance for real business scenarios.
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
MLGO vs QIPT — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $26.3M | $49.0M |
| Net Profit | — | $-1.1M |
| Gross Margin | — | 53.5% |
| Operating Margin | — | 2.1% |
| Net Margin | — | -2.1% |
| Revenue YoY | -35.5% | 32.3% |
| Net Profit YoY | — | 2.9% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $49.0M | ||
| Q3 25 | — | $39.8M | ||
| Q2 25 | $26.3M | $35.1M | ||
| Q1 25 | — | $33.3M | ||
| Q4 24 | $34.6M | $37.1M | ||
| Q2 24 | $40.8M | — | ||
| Q2 23 | $20.2M | — | ||
| Q1 23 | $17.8M | — |
| Q4 25 | — | $-1.1M | ||
| Q3 25 | — | $-3.5M | ||
| Q2 25 | — | $-3.0M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | $4.2M | $-1.1M | ||
| Q2 24 | — | — | ||
| Q2 23 | $-4.8M | — | ||
| Q1 23 | $-1.3M | — |
| Q4 25 | — | 53.5% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | 57.6% | ||
| Q1 25 | — | 54.6% | ||
| Q4 24 | 26.4% | 52.1% | ||
| Q2 24 | — | — | ||
| Q2 23 | 33.0% | — | ||
| Q1 23 | 27.8% | — |
| Q4 25 | — | 2.1% | ||
| Q3 25 | — | -3.6% | ||
| Q2 25 | — | -5.2% | ||
| Q1 25 | — | -3.0% | ||
| Q4 24 | 7.0% | 1.2% | ||
| Q2 24 | — | — | ||
| Q2 23 | -7.7% | — | ||
| Q1 23 | -7.9% | — |
| Q4 25 | — | -2.1% | ||
| Q3 25 | — | -8.9% | ||
| Q2 25 | — | -8.6% | ||
| Q1 25 | — | -9.1% | ||
| Q4 24 | 12.1% | -2.9% | ||
| Q2 24 | — | — | ||
| Q2 23 | -23.7% | — | ||
| Q1 23 | -7.1% | — |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | $0.56 | $-0.03 | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $319.4M | $10.5M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $317.6M | $113.0M |
| Total Assets | $330.8M | $280.7M |
| Debt / EquityLower = less leverage | — | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.5M | ||
| Q3 25 | — | $12.9M | ||
| Q2 25 | $319.4M | $11.3M | ||
| Q1 25 | — | $17.1M | ||
| Q4 24 | $164.9M | $15.5M | ||
| Q2 24 | $66.7M | — | ||
| Q2 23 | $19.2M | — | ||
| Q1 23 | $21.0M | — |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
| Q4 25 | — | $113.0M | ||
| Q3 25 | — | $112.1M | ||
| Q2 25 | $317.6M | $102.5M | ||
| Q1 25 | — | $103.6M | ||
| Q4 24 | $144.9M | $106.3M | ||
| Q2 24 | $76.0M | — | ||
| Q2 23 | $60.4M | — | ||
| Q1 23 | $66.7M | — |
| Q4 25 | — | $280.7M | ||
| Q3 25 | — | $283.3M | ||
| Q2 25 | $330.8M | $236.1M | ||
| Q1 25 | — | $244.6M | ||
| Q4 24 | $176.3M | $242.8M | ||
| Q2 24 | $107.6M | — | ||
| Q2 23 | $71.8M | — | ||
| Q1 23 | $75.6M | — |
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.9M |
| Free Cash FlowOCF − Capex | — | $6.9M |
| FCF MarginFCF / Revenue | — | 14.0% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $26.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.9M | ||
| Q3 25 | — | $9.8M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | — | $8.9M | ||
| Q4 24 | $4.8M | $9.3M | ||
| Q2 24 | — | — | ||
| Q2 23 | $-3.8M | — | ||
| Q1 23 | $-2.8M | — |
| Q4 25 | — | $6.9M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | $4.8M | $5.6M | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | $-2.8M | — |
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 20.0% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | 13.8% | 15.2% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | -15.8% | — |
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 14.9% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | 0.0% | 9.9% | ||
| Q2 24 | 0.0% | — | ||
| Q2 23 | — | — | ||
| Q1 23 | 0.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.15× | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
